Unique ID issued by UMIN | UMIN000031985 |
---|---|
Receipt number | R000036449 |
Scientific Title | Development of predictive and preventive methods for post-esophageal ESD stricture |
Date of disclosure of the study information | 2018/04/15 |
Last modified on | 2023/04/03 13:26:38 |
Development of predictive and preventive methods for post-esophageal ESD stricture
Clinical predictor and prevention of esophageal stricture
Development of predictive and preventive methods for post-esophageal ESD stricture
Clinical predictor and prevention of esophageal stricture
Japan |
superficial esophageal neoplasms
Gastroenterology |
Malignancy
NO
To identify risk factors for esophageal stricture after preventive steroid therapy and examine additional preventive therapy before stricture formation
Efficacy
stricture-free survival
the number of endoscopic balloon dilation for 12 weeks after ESD, adverse events and proportion of patients with dysphagia score=<1 at the time of 12 weeks after ESD
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
A: After local steroid (triamcinolone acetonide 100 mg) injection to the ulcer, prednisolone is started on post-operative day 3 at a dose of 30 mg/day. The administration of steroids was discontinued after 12 weeks.
B: After local steroid (triamcinolone acetonide 100 mg) injection to the ulcer, patients receive no additional treatment.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients over 20 years of age
2)Patients who are histologically proven esophageal squamous cell carcinoma or intraepithelial neoplasia
3)Patients with primary tumor located in the epithelium, lamina propria mucosa, muscularis mucosa or submucosa confirmed by endoscopy
4)Patients with dysphagia score of 0
5)Patients who admit to a hospital
6)Patients with written informed consent.
1)Patients with prior radiotherapy to the neck, chest wall, lung, or mediastinum
2)Patients with primary tumor located within 20mm from prior EMR/ESD treatment site
3)Patients who fail to pass through the prior EMR/ESD treatment site by a standard endoscope (for the upper gastrointestinal tract)
4)Patients with surgery or radiotherapy for esophagus within 3 months after esophageal ESD
5)Patients who judged inappropriate by an attendant physician
74
1st name | Mikihiro |
Middle name | |
Last name | Fujiya |
Asahikawa Medical University
Division of Gastroenterology and Hematology/Oncology, Department of Medicine
078-8510
2-1-1-1, Midorigaoka-higashi Asahikawa, Hokkaido, 078-8510, Japan
0166-68-2462
fjym@asahikawa-med.ac.jp
1st name | Keitaro |
Middle name | |
Last name | Takahashi |
Asahikawa Medical University
Division of Gastroenterology and Hematology/Oncology, Department of Medicine
078-8510
2-1-1-1, Midorigaoka-higashi Asahikawa, Hokkaido, 078-8510, Japan
0166-68-2462
ktakaha@asahikawa-med.ac.jp
Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University
None
Self funding
Asahikawa-Kosei General Hospital
Asahikawa City hospital
Japanese Red Cross Asahikawa Hospital
Asahikawa Medical University Research Ethics Committee
2-1-1-1, Midorigaoka-higashi Asahikawa, Hokkaido, 078-8510, Japan
0166-68-2297
rs-kk.g@asahikawa-med.ac.jp
NO
2018 | Year | 04 | Month | 15 | Day |
Unpublished
Open public recruiting
2018 | Year | 03 | Month | 28 | Day |
2018 | Year | 03 | Month | 28 | Day |
2018 | Year | 03 | Month | 29 | Day |
2023 | Year | 04 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036449